PPL Corp (PPL) Pops 2.65% for February 01

Equities Staff |

One of the S&P 500’s big winners for Monday February 01 was PPL Corp (PPL) as the company’s stock climbed 2.65% to $35.99 on volume of 8.05 million shares.

The stock opened at $35.15 and saw an intraday low of $35.08 and an intraday high of $36.10. All told, the day saw a per-share gain of $0.93. The stock’s average daily volume of 4.81 million and 672.85 million shares outstanding. PPL Corp now has a 50-day SMA is $33.62 and 200-day SMA is $32.08, and it has a 52-week high of $36.74 and a 52-week low of $29.18.

PPL Corp is an energy and utility holding company through its subsidiaries, is engaged in the generation and marketing of electricity in the northeastern and western U.S. and in the delivery of electricity in Pennsylvania and the U.K.

Based out of Allentown, PA, PPL Corp has 17,391 employees and, after today’s trading, reached a market cap of $24.22 billion. The stock’s P/E Ratio is 23.3. Its P/S ratio is 4.01, P/B ratio is 2.37, and P/FCF ratio is -17.4.

For a complete fundamental analysis analysis of PPL Corp, check out Equities.com’s Stock Valuation Analysis report for PPL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.